Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV

End-of-day quote. End-of-day quote  - 01/26
106.71 USD   -1.26%
06/19DJMedtronic Boosts Dividend, Adds To Buyback
06/19DJMedtronic Boosts Dividend, Adds To Buyback
06/09DJCompanies Set Up Advisory Boards to Improve Digital Savvy
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Covidien plc : Covidien Recalls Duet TRS Staplers on Anatomical Injury Potential

08/22/2012 | 09:55am US/Eastern
   By Saabira Chaudhuri 
 

Covidien PLC (COV) is voluntarily recalling its Duet TRS staplers after receiving one report that links the tissue reinforcement material to a post-operative injury after abdominal surgery.

Launched in 2009, the product is a tissue reinforcement system to support staple lines. To date, Covidien has sold more than 540,000 worldwide.

Covidien on Wednesday said it has stopped manufacturing the units, after concluding that Duet TRS may have the potential to injure adjacent anatomical structures, which may result in life threatening post-operative complications.

The affected product codes range between 4535 to 6048A.

The most recent recall is in addition to one unveiled in January relating to the contraindication of the device in the thoracic cavity. At that time, Covidien received reports of 13 serious injuries and three fatalities following the application of Duet TRS in the thoracic cavity.

On Wednesday, the company said all Duet TRS products can be returned by emailing feedback.customerservice@covidien.com or calling 1-800-722-8772, option 1, to obtain a return goods authorization prior to returning the affected units.

People can report adverse events or quality problems related to the product by calling or emailing the Food and Drug Administration's MedWatch Adverse Event Reporting program.

Write to Saabira Chaudhuri at saabira.chaudhuri@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on COVIDIEN PLC
06/19DJMedtronic Boosts Dividend, Adds To Buyback
06/19DJMedtronic Boosts Dividend, Adds To Buyback
06/09DJCompanies Set Up Advisory Boards to Improve Digital Savvy
06/07DJLingering In Antitrust Limbo
06/02DJMedtronic Swings to Loss in First Quarter After Covidien Deal
05/19DJMedtronic Expects Profit at High End of Outlook
05/19DJMedtronic Expects Profit at High End of Outlook
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--4th Update
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--3rd Update
04/08DJMylan Bids $205/Share for Generic Drug Maker Perrigo--3rd Update
Advertisement
Chart
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Income Statement Evolution
More Financials